Acute phase reactants in patients with abdominal aortic aneurysm

被引:57
作者
Domanovits, H
Schillinger, M
Müllner, M
Hölzenbein, T
Janata, K
Bayegan, K
Laggner, AN
机构
[1] Univ Vienna, Vienna Gen Hosp, Dept Emergency Med, A-1090 Vienna, Austria
[2] Univ Vienna, Vienna Gen Hosp, Dept Angiol, A-1090 Vienna, Austria
[3] Univ Vienna, Vienna Gen Hosp, Dept Vasc Surg, A-1090 Vienna, Austria
关键词
abdominal aortic aneurysm; inflammation; CRP; rupture;
D O I
10.1016/S0021-9150(02)00006-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is increasing evidence that an inflammatory process is present in abdominal aortic aneurysms (AAAs) to varying degrees. The aim of this study was to compare acute phase reactants in patients with asymptomatic AAA, symptomatic AAA without rupture and ruptured AAA. Method: Two hundred and twenty-five consecutive patients treated because of AAA were included in this case-control study. Polynomial logistic regression analysis was applied to compare admission C-reactive protein (CRP) and white blood count (WBC) measured in I I I asymptomatic outpatients, 52 symptomatic patients without rupture and 62 patients with rupture of the aneurysm. We adjusted for the potentially confounding effect of age, sex, haemoglobin levels and aneurysm diameter. Results: Patients with symptomatic AAA and patients with ruptured AAA had significantly elevated CRP (p = 0.002) and WBC (p < 0.0001) levels compared to asymptomatic patients. There was no statistically significant difference in CRP and WBC between patients with symptomatic AAA and ruptured AAA. Median CRP values of asymptomatic, symptomatic and ruptured AAA were < 0.5 (interquartile range (IQR) < 0.5-0.85), 1.1(IQR < 0.5-4.0) and 2.4 mg/dl (IQR 0.65-8.6), respectively, and median WBC values were 6.5 (IQR 5.5-8.0), 8.7 (IQR 6.8-11.2) and 13.2 (IQR 10.5-17.0), respectively. Conclusion: A significant elevation of CRP and WBC could be found in patients who presented with symptoms or rupture of an AAA. These indicators of inflammation were not observed in asymptomatic patients with AAA. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:297 / 302
页数:6
相关论文
共 32 条
[1]   The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms [J].
Bigatel, DA ;
Elmore, JR ;
Carey, DJ ;
Cizmeci-Smith, G ;
Franklin, DP ;
Youkey, JR .
JOURNAL OF VASCULAR SURGERY, 1999, 29 (01) :130-138
[2]  
BOWER TC, 1989, SURG CLIN N AM, V69, P745
[3]   Pharmacologic suppression of experimental abdominal aortic aneurysms: A comparison of doxycycline and four chemically modified tetracyclines [J].
Curci, JA ;
Petrinec, D ;
Liao, SX ;
Golub, LM ;
Thompson, RW .
JOURNAL OF VASCULAR SURGERY, 1998, 28 (06) :1082-1093
[4]   Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies [J].
Danesh, J ;
Collins, R ;
Appleby, P ;
Peto, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1477-1482
[5]  
DARKE SG, 1973, J CARDIOVASC SURG, V14, P484
[6]   Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms [J].
Davis, V ;
Persidskaia, R ;
Baca-Regen, L ;
Itoh, Y ;
Nagase, H ;
Persidsky, Y ;
Ghorpade, A ;
Baxter, BT .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) :1625-1633
[7]  
Grange J J, 1997, Cardiovasc Surg, V5, P256, DOI 10.1016/S0967-2109(97)00018-5
[8]  
HEINRICH J, 1995, THROMB HAEMOSTASIS, V73, P374
[9]   SUGGESTED STANDARDS FOR REPORTING ON ARTERIAL ANEURYSMS [J].
JOHNSTON, KW ;
RUTHERFORD, RB ;
TILSON, MD ;
SHAH, DM ;
HOLLIER, L ;
STANLEY, JC .
JOURNAL OF VASCULAR SURGERY, 1991, 13 (03) :452-458
[10]   Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm [J].
Juvonen, J ;
Surcel, HM ;
Satta, J ;
Teppo, AM ;
Bloigu, A ;
Syrjala, H ;
Airaksinen, J ;
Leinonen, M ;
Saikku, P ;
Juvonen, T .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2843-2847